SCHEMBL6182565

SCHEMBL6182565

O=C(c1nc(-c2ccc(Cl)cc2)nc2ccc(Cl)cc12)N1CCC(N2CCC[C@@H](C(=O)N3CCOCC3)C2)CC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACACB O00763 3/20 0.55
ACACA Q13085 3/20 0.55
LMNA P02545 2/20 0.52
GAA P10253 1/20 0.52
PIK3CA P42336 2/20 0.42
MTOR P42345 2/20 0.42
PIK3CG P48736 2/20 0.42
ADRA1A P35348 2/20 0.42
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42
CYP1A2 P05177 1/20 0.42
HPGD P15428 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
MOK Q9UQ07 2/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
MAPT P10636 1/20 0.41
EPHX2 P34913 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.40
L3MBTL3 Q96JM7 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6184775 0.93 ACACB (0.54) ACACBACACALMNAGAAPIK3CA
SCHEMBL6181956 0.87 LMNA (0.53) ACACBACACALMNAGAAPIK3CA
SCHEMBL6181913 0.84 LMNA (0.58) ACACBACACALMNAGAAPIK3CA
SCHEMBL6180226 0.82 ACACB (0.58) ACACBACACALMNAGAA
SCHEMBL6183582 0.79 ACACB (0.52) ACACBACACALMNAGAAKDM4E
SCHEMBL6183490 0.79 ALDH1A1 (0.58) ACACBACACALMNAGAAKDM4E
SCHEMBL6183609 0.76 ACACB (0.71) ACACBACACALMNAALDH1A1
SCHEMBL6182985 0.76 MOK (0.48) ACACBACACALMNAGAAKDM4E
SCHEMBL977857 0.76 ACACB (0.51) ACACBACACALMNAGAAADRA1A
SCHEMBL6184192 0.76 ACACB (0.51) ACACBACACALMNAGAAADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6979741-B2 Acetyl-CoA carboxylase inhibitors PFIZER INC. (US) 2005-12-27 US disclosed
EP-1478437-B1 ACC INHIBITORS PFIZER PROD INC (US) 2005-08-31 EP disclosed
US-20030187254-A1 Acetyl-CoA carboxylase inhibitors PFIZER INC. 2003-10-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030187254-A1 Acetyl-CoA carboxylase inhibitors ACACA, ACACB, ACAT1 ACACB 2/4885ACACA 1/4885LMNA 2199/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.